Pluristem Therapeutics, Inc. (PSTI): Price and Financial Metrics
Pluristem Therapeutics, Inc. (PSTI)
Today's Latest Price: $10.69 USD
Updated Dec 4 11:33am
Add PSTI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PSTI Stock Summary
- The ratio of debt to operating expenses for Pluristem Therapeutics Inc is higher than it is for about just 7.88% of US stocks.
- With a price/sales ratio of 11,702.2, Pluristem Therapeutics Inc has a higher such ratio than 99.8% of stocks in our set.
- Revenue growth over the past 12 months for Pluristem Therapeutics Inc comes in at -54%, a number that bests just 4.41% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Pluristem Therapeutics Inc, a group of peers worth examining would be NK, AUPH, VTVT, PRKR, and CYAD.
- Visit PSTI's SEC page to see the company's official filings. To visit the company's web site, go to www.pluristem.com.
PSTI Stock Price Chart Interactive Chart >
PSTI Price/Volume Stats
| Current price | $10.69 | 52-week high | $13.29 |
| Prev. close | $10.67 | 52-week low | $2.82 |
| Day low | $10.55 | Volume | 107,435 |
| Day high | $10.88 | Avg. volume | 883,106 |
| 50-day MA | $9.89 | Dividend yield | N/A |
| 200-day MA | $8.37 | Market Cap | 274.02M |
Pluristem Therapeutics, Inc. (PSTI) Company Bio
Pluristem Therapeutics Inc. operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic and inflammatory conditions. The company was founded in 2001 and is based in Haifa, Israel.
Loading social stream, please wait...